Routine testing conducted by ALK-Abelló has revealed that during the production process in some batches the needle may have become bent, causing the needle to curl up inside the injector housing upon activation and consequently causing the pen not to deliver the required adrenaline dose. The malfunction only affects a small number, approximately 1 in 2500, of the pens in these batches. Immediate action has been taken to eliminate similar production issues in the future. For more information click here.
Comments
RT @ProTrainingsEU: Important safety information for patients using Jext® solution for injection in pre-filled pen: Routine testing co… h…
RT @ProTrainingsEU: Important safety information for patients using Jext® solution for injection in pre-filled pen: Routine testing co… h…
RT @ProTrainingsEU: Important safety information for patients using Jext® solution for injection in pre-filled pen: Routine testing co… h…
RT @ProTrainingsEU: Important safety information for patients using Jext® solution for injection in pre-filled pen: Routine testing co… h…
RT @ProTrainingsEU: Important safety information for patients using Jext® solution for injection in pre-filled pen: Routine testing co… h…
RT @ProTrainingsEU: Important safety information for patients using Jext® solution for injection in pre-filled pen: Routine testing co… h…
RT @ProTrainingsEU: Important safety information for patients using Jext® solution for injection in pre-filled pen: Routine testing co… h…
Important safety information for patients using Jext® solution for injection in pre-filled pen http://t.co/hPhM37qG12
RT @ProTrainingsEU: Important safety information for patients using Jext® solution for injection in pre-filled pen http://t.co/hPhM37qG12
Pingback: Course of the week – Manual Handling | ProTrainings UK Blog
Pingback: National Review of Asthma Deaths Released | ProTrainings UK Blog
Pingback: Viral Meningitis Awareness Week | ProTrainings UK Blog
Pingback: Course of the Week – The Emergency First Aid at Work course (EFAW) | ProTrainings UK Blog
Pingback: Skin cancer trial results 'exciting' | ProTrainings UK Blog